Evoke Pharma (EVOK) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Join SI Premium – FREE
Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $1.56 million versus the consensus estimate of $1.26 million.
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loews Corp. (L) Reports Q3 EPS of $1.50
- Lattice Semiconductor (LSCC) Tops Q3 EPS by 17c, Beats on Revenue
- Advanced Energy Industries (AEIS) Tops Q3 EPS by 61c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
